Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution
- 19 February 2004
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 19 (6) , 1546-1551
- https://doi.org/10.1093/ndt/gfh014
Abstract
The use of haemodialysis catheters is complicated by catheter-related sepsis. Intraluminal colonization of the catheter with bacteria is important in the pathogenesis of catheter-related sepsis. The use of a catheter lock solution containing the antimicrobial taurolidine might prevent bacterial colonization, thereby reducing the incidence of catheter-related sepsis. In a randomized prospective trial, patients receiving a dialysis catheter were included and catheters were locked with either heparin or a citrate-taurolidine-containing solution. Blood cultures drawn from the catheter lumen were routinely taken every 2 weeks and at time of removal of the catheter to detect bacterial colonization. Catheter-related sepsis and exit-site infections were registered for both groups. A total of 76 catheters were inserted in 58 patients. The incidence of catheter colonization progressed slowly over time with no differences between dialysis catheters filled with heparin or citrate-taurolidine-containing solution. The number of exit-site infections was also similar between both groups. In the heparin group, four cases of catheter-related sepsis occurred as opposed to no sepsis episodes in the patients with catheters locked with the citrate-taurolidine-containing solution (P<0.5). No side effects with the use of citrate-taurolidine catheter lock solution were noted. This study shows that catheter filling with a solution containing the antimicrobial taurolidine may significantly reduce the incidence of catheter-related sepsis. Taurolidine appears to be effective and safe and does not carry the risk for side effects that have been reported for other antimicrobial lock solutions containing gentamicin or high concentrations of citrate.Keywords
This publication has 19 references indexed in Scilit:
- Prophylaxis against Dialysis Catheter-Related Bacteremia with a Novel Antimicrobial Lock SolutionClinical Infectious Diseases, 2003
- Superior antimicrobial activity of trisodium citrate over heparin for catheter lockingNephrology Dialysis Transplantation, 2002
- Prevention of Tunneled Hemodialysis Catheter-Related Infections Using Catheter-Restricted Filling with Gentamicin and CitrateJournal of the American Society of Nephrology, 2002
- Antimicrobial Activity of a Novel Catheter Lock SolutionAntimicrobial Agents and Chemotherapy, 2002
- Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solutionKidney International, 2002
- Two Years’ Experience with Dialock® and CLSTM (A New Antimicrobial Lock Solution)Blood Purification, 2000
- Activities of Taurolidine In Vitro and in Experimental Enterococcal EndocarditisAntimicrobial Agents and Chemotherapy, 2000
- Bacteremia associated with tunneled, cuffed hemodialysis cathetersAmerican Journal of Kidney Diseases, 1999
- Taurolidine 2% as an Antimicrobial Lock Solution for Prevention of Recurrent Catheter‐Related Bloodstream InfectionsJournal of Parenteral and Enteral Nutrition, 1998
- Intravascular-catheter-related infectionsThe Lancet, 1998